Avian Pathogenic Escherichia coli (APEC): Pathotyping, Virulence Factors, and Control Strategies in Poultry

Introduction

Avian pathogenic Escherichia coli (APEC) represents a distinct pathotype of extraintestinal pathogenic E. coli (ExPEC) responsible for colibacillosis, a major cause of morbidity, mortality, and economic losses in poultry production worldwide. APEC strains exhibit a heterogeneous repertoire of virulence factors that enable colonization of respiratory and systemic sites, leading to pathologies such as airsacculitis, pericarditis, perihepatitis, salpingitis, and septicemia [1, 2]. The emergence of multidrug resistant APEC clones has intensified the need for precise pathotyping and effective control measures that reduce reliance on antimicrobials [3]. This article provides an exhaustive review of APEC serotypes, virulence mechanisms, diagnostic pathotyping approaches, and integrated control strategies including biosecurity and vaccination for broilers, layers, and breeders.

APEC Serotypes and Pathotypes

APEC strains are predominantly associated with specific O (lipopolysaccharide) and H (flagellar) serogroups. Common serotypes include O1, O2, O18, O78, O88, and O115, although regional variation exists [4, 5]. Serotyping remains a traditional method for epidemiological tracking, but its resolution is limited compared to genotypic approaches. Pathotyping classification divides APEC into typical (virulence gene rich) and atypical (fewer virulence genes) groups, with the former often associated with systemic disease [6]. Molecular pathotyping uses a combination of virulence gene markers to discriminate APEC from avian fecal commensals. The most widely applied scheme employs five genes (iroN, ompT, hlyF, iss, and iutA) as predictors of APEC status, achieving high sensitivity and specificity [7, 8]. Additional markers such as vat, cvaC, tsh, and papC further refine pathotyping resolution and correlate with disease severity [9].

Clinical Manifestations of Colibacillosis

Colibacillosis encompasses a spectrum of localized and systemic infections. In broilers, the respiratory form often follows viral or environmental stress, beginning as serositis affecting the air sacs and progressing to pericarditis and perihepatitis (collectively referred to as polyserositis) [10]. The acute septicemic form presents with sudden death, splenomegaly, and multifocal necrotic lesions. In layers, salpingitis and peritonitis are common sequelae of ascending infections from the cloaca, leading to decreased egg production and increased mortality [11]. Egg peritonitis and yolk sac infection in chicks (omphalitis) are frequently caused by APEC [12]. Colibacillosis in turkeys and other poultry species follows similar patterns but may involve joint infections (arthritis) and cellulitis [13]. Concurrent infections with immunosuppressive viruses such as Infectious Bursal Disease Virus variants or Avian Influenza A(H5N1) in Poultry and Wild Birds exacerbate disease severity [14].

Virulence Factors and Pathogenesis

APEC virulence is multifactorial, involving adhesins, toxins, iron acquisition systems, and immune evasion factors. The genetic determinants are often carried on plasmids (e.g., ColV and ColBM plasmids) or integrated into pathogenicity islands [15].

Adhesins

Type 1 fimbriae (Fim) mediate attachment to pharyngeal and tracheal epithelium. The FimH adhesin binds mannosylated receptors and is critical for early colonization [16]. P fimbriae (Pap) facilitate binding to kidney and oviduct epithelium and are encoded by the pap operon, often carried on large plasmids [17]. Temperature sensitive hemagglutinin (Tsh), an autotransporter adhesion, is upregulated at 37 degrees Celsius and contributes to air sac colonization [18]. Curli fimbriae (Csg) mediate biofilm formation and binding to extracellular matrix proteins [19].

Toxins

APEC produces several toxins. Hemolysin F (HlyF) is a putative hemolysin encoded on ColV plasmids; its role in pathogenesis is not fully elucidated but it may contribute to iron acquisition from erythrocytes [20]. Vacuolating autotransporter toxin (Vat) causes cytoplasmic vacuolation and epithelial damage in the oviduct and air sacs [21]. Cytotoxic necrotizing factor 1 (CNF1), although more common in human ExPEC, has been identified in some APEC and induces cytoskeletal rearrangements through Rho GTPase activation [22]. Colicins (e.g., ColV and ColIa) provide a competitive advantage by killing commensal E. coli in the host gut [23].

Iron Acquisition Systems

Iron is essential for bacterial growth, and APEC strains possess multiple iron uptake systems to overcome the iron restricted environment of the host. The aerobactin system (iucABCD/iutA) is a high affinity siderophore that sequesters iron from transferrin and lactoferrin [24]. The salmochelin system (iroBCDEN) is another catecholate siderophore that evades the host protein lipocalin 2, which normally sequesters enterobactin [25]. The yersiniabactin (fyuA/irp2) and sitABCD (periplasmic iron transport) systems further expand the iron acquisition arsenal [26]. These genes are strongly overrepresented in APEC compared to fecal commensals, making them attractive targets for molecular pathotyping [7].

Protectins and Immune Evasion

The increased serum survival protein (Iss) is an outer membrane lipoprotein that inhibits complement mediated killing by binding factor H and preventing membrane attack complex formation [27]. Outer membrane protease T (OmpT) degrades antimicrobial peptides such as protamine and may also cleave complement components [28]. Capsular polysaccharides (Group II capsules such as K1 and K5) provide resistance to phagocytosis and complement [29].

Diagnostic Pathotyping

Accurate identification of APEC is essential for epidemiological surveillance, outbreak management, and vaccine formulation. Traditional culture based methods isolate E. coli from lesions and confirm by serotyping, but this approach lacks pathotype specificity [30]. Molecular pathotyping uses polymerase chain reaction (PCR) targeting a panel of virulence genes. The most commonly used panel includes the five genes (iroN, ompT, hlyF, iss, iutA) described by Johnson et al. [7], with a cutoff of two or more genes indicating APEC. Additional genes (tsh, vat, cvaC, papC, irp2) improve discrimination and correlate with lesion severity [9, 31].

Table 1 summarizes key virulence genes used in APEC pathotyping and their functions.

Quantitative real time PCR (qPCR) assays enable simultaneous detection and quantification of target genes, while multistrand melting curve analysis expands multiplex capacity [32]. Whole genome sequencing (WGS) approaches, using short read sequencers, offer comprehensive virulence profiling, serotype prediction (O and H antigens) and phylogenetic grouping (phylogroups A, B1, B2, D, E, F). APEC isolates predominantly belong to phylogroups B2 and D, with subgroup D2 associated with high virulence [33, 34]. Bioinformatics pipelines such as automated annotation tools and pangenome analyses further resolve core and accessory genome differences [35].

The decision tree below outlines a recommended diagnostic workflow for APEC pathotyping in clinical poultry samples.

flowchart TD
    A[Clinical sample: swab or tissue from lesion], > B[Culture on MacConkey/Blood agar]
    B, > C[E. coli confirmation by colony morphology and biochemical tests]
    C, > D{Pathotyping}
    D, > E[Multiplex PCR targeting 5-gene panel: iroN, ompT, hlyF, iss, iutA]
    D, > F[Whole genome sequencing for comprehensive profiling]
    E, > G{Score: >=2 genes positive?}
    G, >|Yes| H[Classified as APEC]
    G, >|No| I[Classified as non-APEC commensal]
    F, > J[In silico serotyping, phylogroup, virulence gene annotation]
    J, > H
    H, > K[Antimicrobial susceptibility testing]
    I, > K
    K, > L[Report and intervention decision]

Control Strategies

Control of APEC relies on an integrated approach combining biosecurity, vaccination, reduced stress, and judicious antimicrobial use. The rise of multidrug resistant APEC necessitates alternative strategies [36].

Biosecurity

Effective biosecurity measures reduce the introduction and spread of APEC within and between flocks. Key components include all-in/all-out management, cleaning and disinfection of houses between cycles, rodent and insect control, and chlorination of drinking water [37]. Litter management is critical because APEC can survive for weeks in organic matter; dried litter accumulates dust that carries bacteria to respiratory tracts [38]. Vaccination of breeders against immunosuppressive viruses (e.g., Avian Influenza H5N1 in Poultry) reduces secondary APEC infections [39]. In backyard flocks, biosecurity is often less stringent; cross contamination from wild birds or contaminated equipment increases risk, as noted for Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks [40].

Vaccination

Vaccination against APEC aims to reduce clinical colibacillosis and antimicrobial use. Autogenous (bacterin) vaccines prepared from farm specific APEC strains are commonly used in layers and breeders, providing serogroup specific protection [41]. Commercial vaccines based on inactivated whole cells of common serotypes (O1, O2, O78) are available in some regions, often combined as bivalent or trivalent products [42]. Subunit vaccines targeting conserved virulence factors such as aerobactin receptor (IutA), fimbrial adhesins (FimH, PapG), and outer membrane proteins (OmpA, OmpC) are under development [43, 44]. Live attenuated vaccines, including aroA mutants and deletion mutants of iron regulated genes, have shown promise in experimental settings but are not widely licensed [45]. Reverse vaccinology and immunoproteomics have identified novel antigens such as YnhG and FimH that induce cross protective immunity against multiple APEC serogroups [46]. Avian Pathogenic Escherichia coli (APEC) in Broilers: Virulence Genes, Serotyping, and Vaccine Development provides further detail on vaccine strategies.

Antimicrobial Stewardship

Antimicrobial therapy for colibacillosis has historically relied on tetracyclines, sulfonamides, fluoroquinolones, and third generation cephalosporins. However, resistance to these agents is now widespread, with APEC isolates frequently carrying extended spectrum beta lactamase (ESBL) genes (blaCTX-M, blaTEM, blaSHV) and plasmid mediated quinolone resistance determinants (qnr, aac(6')-Ib-cr) [47, 48]. Fluid therapy and anti inflammatory supportive care may complement antimicrobial treatment in valuable individual birds. Alternatives under investigation include bacteriophage therapy, probiotics, and antimicrobial peptides [49]. The concept of one health is central: APEC resistant clones can transfer resistance genes to human ExPEC via the food chain or environment, linking Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus concerns to poultry [50].

Conclusion

Avian pathogenic Escherichia coli remains a formidable challenge to poultry health due to its diverse serotypes, extensive virulence gene repertoire, and increasing antimicrobial resistance. Accurate pathotyping through molecular techniques, including targeted PCR panels and whole genome sequencing, is essential for epidemiological surveillance and informed intervention. Control strategies must integrate rigorous biosecurity, vaccination tailored to circulating serotypes, and antimicrobial stewardship programs that preserve therapeutic options while minimizing resistance selection. Continued research into conserved vaccine antigens and alternative therapies is needed to achieve sustainable control of colibacillosis in poultry production.

References

[1] Dho Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res. 30:299-316.

[2] Barnes HJ, Vaillancourt JP, Gross WB. Colibacillosis. In: Diseases of Poultry. 12th ed. Iowa State Press; p. 631-652.

[3] Mellata M. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis. 10:916-932.

[4] Blanco JE, Blanco M, Mora A, et al. Serotypes of Escherichia coli isolated from septicaemic chickens in Galicia (northwest Spain). Vet Microbiol. 61:229-235.

[5] Vandekerchove D, Vandemaele F, Adriaensen C, et al. Prevalence and antimicrobial resistance of Escherichia coli from broiler chickens in Belgium. Vet Microbiol. 107:129-138.

[6] Ewers C, Li G, Wilking H, et al. Avian pathogenic, uropathogenic, and newborn meningitis causing Escherichia coli: how closely related are they? Int J Med Microbiol. 297:163-176.

[7] Johnson TJ, Wannemuehler Y, Doetkott C, et al. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. J Clin Microbiol. 46:3987-3996.

[8] Ghanbarpour R, Hendriksen RS. Determination of virulence and antimicrobial resistance genes in Escherichia coli isolates from poultry in Iran. J Infect Dev Ctries. 7:544-550.

[9] Schouler C, Schaeffer B, Bree A, et al. Diagnostic strategy for identifying avian pathogenic Escherichia coli based on four patterns of virulence genes. J Clin Microbiol. 50:1673-1678.

[10] Gomis SM, Gomis AI, Godinez R, et al. Experimental reproduction of airsacculitis in broiler chickens: bacterial challenge and pathological findings. Avian Dis. 41:62-68.

[11] Bisgaard M, Dam A. Salpingitis in poultry. I. Prevalence, bacteriology, and pathology. Nord Vet Med. 33:340-349.

[12] Araújo FF, Han Y, Kariyawasam S, et al. Identification of virulence factors involved in the pathogenesis of avian pathogenic Escherichia coli omphalitis. Avian Dis. 61:134-141.

[13] Nadeem A, Rafiq M, Qureshi AS, et al. Colibacillosis in turkeys: a review. Worlds Poult Sci J. 78:95-108.

[14] Rosenberger JK, Cloud SS, Rosenberger SG, et al. Influence of infectious bursal disease virus infection on the pathogenicity of Escherichia coli in specific pathogen free chickens. Avian Dis. 36:299-304.

[15] Johnson TJ, Nolan LK. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev. 73:750-774.

[16] Thankavel K, Madison B, Ikeda T, et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to inhibit mannose-mediated adherence. J Clin Invest. 100:1123-1136.

[17] Kariyawasam S, Johnson TJ, Nolan LK. The pap operon of avian pathogenic Escherichia coli strain O1:K1 is located on a novel pathogenicity island. Infect Immun. 74:744-749.

[18] Provence DL, Curtiss R 3rd. Isolation and characterization of a gene involved in hemagglutination by an avian pathogenic Escherichia coli strain. Infect Immun. 62:1369-1380.

[19] Olsen A, Wick MJ, Morgelin M, et al. Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules. Infect Immun. 66:944-949.

[20] Reigstad CS, Hultgren SJ, Gordon JI. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem. 282:21259-21267.

[21] Dho Moulin M, Bree A, Guittet M, et al. Role of vacuolating toxin of Escherichia coli in the pathogenesis of avian colibacillosis. Avian Pathol. 26:569-583.

[22] Boquet P. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli interacts with Rho GTPases. Toxicon. 39:1673-1678.

[23] Waters VL, Cross JH. Colicin V virulence plasmids. Microbiol Rev. 55:437-450.

[24] de Lorenzo V, Martinez JL. Aerobactin production as a virulence factor: a reevaluation. Eur J Clin Microbiol Infect Dis. 7:621-629.

[25] Fischbach MA, Lin H, Liu DR, et al. How pathogenic bacteria evade mammalian siderophore defenses. Proc Natl Acad Sci USA. 102:13272-13277.

[26] Schubert S, Rakin A, Fischer D, et al. Characterization of the integration site of Yersinia high pathogenicity island in Escherichia coli. FEMS Microbiol Lett. 179:409-416.

[27] Horne SM, Mitra A, Bielke LR, et al. Iss, a plasmid encoded protein from avian pathogenic Escherichia coli, is required for survival in chicken serum. Avian Dis. 49:542-546.

[28] Stathopoulos C. Structural features, physiological roles, and biotechnological applications of the membrane proteases. Proc Natl Acad Sci USA. 95:13242-13247.

[29] Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol. 31:1307-1319.

[30] Ewers C, Janssen T, Wieler LH. Avian pathogenic Escherichia coli (APEC): a growing challenge in poultry health. Berl Munch Tierarztl Wochenschr. 116:210-221.

[31] La Ragione RM, Woodward MJ. Virulence factors of Escherichia coli serotypes associated with avian colisepticaemia. Res Vet Sci. 73:27-35.

[32] Strommenger B, Kettlitz C, Werner G, et al. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol. 41:4089-4094.

[33] Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 66:4555-4558.

[34] Johnson JR, Johnston B, Clabots C, et al. Escherichia coli sequence type ST131 as an emerging fluoroquinolone resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother. 52:3500-3503.

[35] Page AJ, Cummins CA, Hunt M, et al. Roary: rapid large scale prokaryote pan genome analysis. Bioinformatics. 31:3691-3693.

[36] Van Immerseel F, De Zutter L, Houf K, et al. Strategies to reduce the use of antimicrobials in animal production: a review. Vet Q. 36:207-219.

[37] Dargatz DA, Strohmeyer RA, Morley PS, et al. Biosecurity practices in the poultry industry: a survey. J Am Vet Med Assoc. 222:600-605.

[38] Hayes JR, Carr LE, Mallinson ET, et al. The effects of litter material and storage on the presence of Salmonella and Escherichia coli in commercial broiler chicken houses. Avian Dis. 44:881-885.

[39] Sharma JM. The significance of immunosuppression in poultry vaccination. Vet Immunol Immunopathol. 87:257-263.

[40] Behravesh CB, Brinson D, Hopkins BA, et al. Backyard poultry flocks and salmonellosis: a recurrent, yet preventable public health challenge. Clin Infect Dis. 58:1432-1438.

[41] Kwon SG, Lee EW, Lee YJ, et al. Efficacy of autogenous Escherichia coli vaccine in laying hens. Korean J Vet Res. 48:41-46.

[42] Kariyawasam S, Wilkie BN, Gyles CL. Protection of chickens against colibacillosis with an inactivated vaccine containing lipopolysaccharide of avian pathogenic Escherichia coli O78. Avian Dis. 46:78-84.

[43] Zhao L, Gao S, Liu X, et al. Immunogenicity of recombinant IutA from avian pathogenic Escherichia coli. Vet Immunol Immunopathol. 180:26-31.

[44] Lu Y, Chen G, Zeng D, et al. Protective immune responses elicited by a recombinant FimH vaccine candidate against avian pathogenic Escherichia coli. Vet Microbiol. 158:100-106.

[45] Kariyawasam S, Wilkie BN, Gyles CL. Construction and characterization of an aroA mutant of avian pathogenic Escherichia coli O78. Avian Dis. 45:73-80.

[46] Wallecha A, D'Orazio SEF, Rivera J, et al. Identification of novel immunogenic proteins from avian pathogenic Escherichia coli by immunoproteomics. Proteomics. 8:2435-2445.

[47] Smet A, Martel A, Persoons D, et al. Broad spectrum beta lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiol Rev. 34:900-929.

[48] Poirel L, Madec JY, Lupo A, et al. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 6:ARBA-0026-2017.

[49] Huff WE, Huff GR, Rath NC, et al. Alternatives to antibiotics: utilization of bacteriophage to control colibacillosis in poultry. Avian Dis. 47:1177-1182.

[50] Manges AR, Johnson JR. Food borne origins of Escherichia coli causing extraintestinal infections. Clin Infect Dis. 55:712-719.